| Line Item | 2025-12-26 | Y/Y |
|---|---|---|
| Revenue | $947.7M | +11.6% |
| Cost of Revenue | $859.9M | +15.3% |
| Gross Profit | $87.8M | -15.1% |
| R&D Expense | $23.1M | +0.3% |
| SG&A Expense | $95.7M | +20.5% |
| Operating Income | -$39.3M | -414.0% |
| Pre-tax Income | -$47.6M | -163.5% |
| Income Tax | $5.2M | +88.5% |
| Net Income | -$52.8M |
| Line Item | 2025-12-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.3M | -9.6% |
| Accounts Receivable | $70.5M | -18.6% |
| Inventory | $231.8M | -7.3% |
| Current Assets | $410.1M | -9.4% |
| Total Assets | $942.9M | -5.3% |
| Current Liabilities | $129.6M | -4.5% |
| Long-term Debt | $123.5M | -3.9% |
| Line Item | 2025-12-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $29.9M | +7.2% |
| Capital Expenditures | $36.2M | +105.1% |
| Investing Cash Flow | -$36.2M | -105.1% |
| Financing Cash Flow | -$4.1M | -122.2% |
| Free Cash Flow | -$6.3M | -161.3% |
| -153.5% |
| EPS (Basic) | -$1.54 | -140.6% |
| EPS (Diluted) | -$1.54 | -140.6% |
| Total Liabilities |
| $279.0M |
| -6.1% |
| Stockholders' Equity | $663.9M | -4.9% |